lorazepam has been researched along with Dyskinesia, Drug-Induced in 11 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact." | 3.69 | Movement disorders associated with the use of gabapentin. ( Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL, 1996) |
| "The drop in the akathisia score from a pretreatment value of 1." | 2.66 | Treatment of akathisia with lorazepam. An open clinical trial. ( Bartels, M; Heide, K; Mann, K; Schied, HW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohli, N | 1 |
| Bordeaux, JS | 1 |
| Park, YM | 1 |
| Lee, HJ | 1 |
| Kang, SG | 1 |
| Choo, CS | 1 |
| Cho, JH | 1 |
| Sekhar, S | 1 |
| Kalra, B | 1 |
| Mendhekar, DN | 1 |
| Tekur, U | 1 |
| Miller, MA | 1 |
| Levsky, ME | 1 |
| Jeffries, JJ | 1 |
| Northoff, G | 2 |
| Wenke, J | 2 |
| Pflug, B | 2 |
| Reeves, AL | 1 |
| So, EL | 1 |
| Sharbrough, FW | 1 |
| Krahn, LE | 1 |
| Demisch, L | 1 |
| Eckert, J | 1 |
| Gille, B | 1 |
| Stevens, E | 1 |
| Roman, A | 1 |
| Houa, M | 1 |
| Razavi, D | 1 |
| Jaspar, N | 1 |
| Bartels, M | 1 |
| Heide, K | 1 |
| Mann, K | 1 |
| Schied, HW | 1 |
| Sandyk, R | 1 |
3 trials available for lorazepam and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol | 2010 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Treatment of akathisia with lorazepam. An open clinical trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Ind | 1987 |
8 other studies available for lorazepam and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Involuntary movements during periocular reconstruction secondary to lorazepam.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Blepharoplasty; Dyskinesia, Drug-Induced; Humans; Lorazepam; | 2015 |
Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzamides; Benzyl Compounds; B | 2009 |
Choreiform dyskinesia following isolated lamotrigine overdose.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Chorea; Drug Overdose; Dyskinesia, Drug- | 2008 |
Treatment of acute neuroleptic-induced dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Lorazepam | 1983 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, | 1996 |
Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Antidepressive Agents, Second-Generation; Antidepressiv | 1998 |
Orofacial dyskinesias associated with lorazepam therapy.
Topics: Anxiety Disorders; Depressive Disorder; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Lo | 1986 |